|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-6-25
|
|
pubmed:abstractText |
To evaluate the effectiveness and safety of adalimumab in patients with rheumatoid arthritis (RA) who previously discontinued tumour necrosis factor (TNF) antagonists for any reason in clinical practice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/adalimumab,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1462-0324
|
|
pubmed:author |
pubmed-author:BombardieriSS,
pubmed-author:BurmesterG RGR,
pubmed-author:FardellonePP,
pubmed-author:GeusensPP,
pubmed-author:KarpZZ,
pubmed-author:KupperHH,
pubmed-author:McKennaFF,
pubmed-author:OezerUU,
pubmed-author:Research in Active Rheumatoid Arthritis (ReAct) Study Group,
pubmed-author:RuizA AAA,
pubmed-author:UnnebrinkKK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1191-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17504821-Acute Disease,
pubmed-meshheading:17504821-Adult,
pubmed-meshheading:17504821-Antibodies, Monoclonal,
pubmed-meshheading:17504821-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:17504821-Antirheumatic Agents,
pubmed-meshheading:17504821-Arthritis, Rheumatoid,
pubmed-meshheading:17504821-Disability Evaluation,
pubmed-meshheading:17504821-Health Status Indicators,
pubmed-meshheading:17504821-Humans,
pubmed-meshheading:17504821-Immunoglobulin G,
pubmed-meshheading:17504821-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:17504821-Regression Analysis,
pubmed-meshheading:17504821-Remission Induction,
pubmed-meshheading:17504821-Treatment Outcome,
pubmed-meshheading:17504821-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy. s.bombardieri@int.med.unipi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
